Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

BUSAN, South Korea I April 09, 2025 I NexThera Co., Ltd. (CEO:SaeGwang Park) announced on April 9th that it has completed the first patient enrollment for its ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...

Newbury Pharmaceuticals is pleased to announce the successful Marketing Authorization (MA) of Pazopanib Newbury tablets in Sweden as the first country in a Scandinavian registration procedure. Approva ...

And finally, our partner BioCryst recently highlighted plans to initiate clinical testing in 2025 of avoralstat, its plasma kallikrein inhibitor ... were presented at Angiogenesis at Retina ...

tumor invasion and neo-angiogenesis. Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering with several receptor tyrosine kinases involved in the ...

To inspire future developments, we outline key directions to expand the horizons of photodynamic nanomedicine in targeting tumor angiogenesis and metabolism. Develop stimuli-responsive nanocarriers ...

As2O3 has a significant anti-angiogenic effect on the synovium of RA-FLS ... Hypomethylation of pro-angiogenesis genes (e.g., VEGFA, ANGPT2) in RA VEC amplifies synovial angiogenesis. HDAC inhibitors ...

10 Standard therapy for clear cell RCC involves treatment with a PD-1 inhibitor, such as nivolumab (Opdivo), coupled with either an anti–CTLA-4 inhibitor ... RNA sequencing reveals the expression of ...

Options include nonsteroidal anti-inflammatory drugs and painkillers ... are testing other existing drugs in patients with endometriosis, including the angiogenesis inhibitor cabergoline. “Our ...